APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cadonilimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cadonilimab Injection Market Analysis and Forecast 2026-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchCadonilimab Injection Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Cadonilimab Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Cadonilimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cadonilimab Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cadonilimab Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cadonilimab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cadonilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cadonilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cadonilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cadonilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cadonilimab Injection include Akeso Inc.. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cadonilimab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cadonilimab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Cadonilimab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cadonilimab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cadonilimab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cadonilimab Injection sales, projected growth trends, production technology, application and end-user industry.

Cadonilimab Injection Segment by Company

Akeso Inc.

Cadonilimab Injection Segment by Type

125 mg (10 mL)/Bottle

Other

Cadonilimab Injection Segment by Application

Lung Cancer

Liver Cancer

Cervical Cancer

Gastric Cancer

Pancreatic Cancer

Other

Cadonilimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cadonilimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cadonilimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cadonilimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cadonilimab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cadonilimab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cadonilimab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cadonilimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 125 mg (10 mL)/Bottle Major Manufacturers Table 3. Other Major Manufacturers Table 4. Global Cadonilimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Lung Cancer Major Manufacturers Table 6. Liver Cancer Major Manufacturers Table 7. Cervical Cancer Major Manufacturers Table 8. Gastric Cancer Major Manufacturers Table 9. Pancreatic Cancer Major Manufacturers Table 10. Other Major Manufacturers Table 11. Cadonilimab Injection Industry Trends Table 12. Cadonilimab Injection Industry Drivers Table 13. Cadonilimab Injection Industry Opportunities and Challenges Table 14. Cadonilimab Injection Industry Restraints Table 15. Global Cadonilimab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Cadonilimab Injection Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Cadonilimab Injection Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Cadonilimab Injection Revenue Market Share by Region (2021-2026) Table 19. Global Cadonilimab Injection Revenue Market Share by Region (2027-2032) Table 20. Global Cadonilimab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Cadonilimab Injection Sales by Region (2021-2026) & (K Units) Table 22. Global Cadonilimab Injection Sales by Region (2027-2032) & (K Units) Table 23. Global Cadonilimab Injection Sales Market Share by Region (2021-2026) Table 24. Global Cadonilimab Injection Sales Market Share by Region (2027-2032) Table 25. Global Cadonilimab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Cadonilimab Injection Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Cadonilimab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Cadonilimab Injection Sales Market Share by Manufacturers (2021-2026) Table 29. Global Cadonilimab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Cadonilimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Cadonilimab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Cadonilimab Injection Manufacturers, Product Type & Application Table 33. Global Cadonilimab Injection Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Cadonilimab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Cadonilimab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Cadonilimab Injection Revenue Market Share by Type (2021-2026) Table 40. Global Cadonilimab Injection Revenue Market Share by Type (2027-2032) Table 41. Global Cadonilimab Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 43. Global Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 44. Global Cadonilimab Injection Sales Market Share by Type (2021-2026) Table 45. Global Cadonilimab Injection Sales Market Share by Type (2027-2032) Table 46. Global Cadonilimab Injection Price by Type (2021-2026) & (US$/Unit) Table 47. Global Cadonilimab Injection Price by Type (2027-2032) & (US$/Unit) Table 48. Global Cadonilimab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Cadonilimab Injection Revenue Market Share by Application (2021-2026) Table 52. Global Cadonilimab Injection Revenue Market Share by Application (2027-2032) Table 53. Global Cadonilimab Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 55. Global Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 56. Global Cadonilimab Injection Sales Market Share by Application (2021-2026) Table 57. Global Cadonilimab Injection Sales Market Share by Application (2027-2032) Table 58. Global Cadonilimab Injection Price by Application (2021-2026) & (US$/Unit) Table 59. Global Cadonilimab Injection Price by Application (2027-2032) & (US$/Unit) Table 60. Akeso Inc. Company Information Table 61. Akeso Inc. Business Overview Table 62. Akeso Inc. Cadonilimab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Akeso Inc. Cadonilimab Injection Product Portfolio Table 64. Akeso Inc. Recent Development Table 65. North America Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 66. North America Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 67. North America Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 68. North America Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 69. North America Cadonilimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 70. North America Cadonilimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 71. North America Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 74. North America Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 75. North America Cadonilimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 76. North America Cadonilimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 77. North America Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. North America Cadonilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 79. North America Cadonilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 80. North America Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 81. North America Cadonilimab Injection Sales by Country (2021-2026) & (K Units) Table 82. North America Cadonilimab Injection Sales by Country (2027-2032) & (K Units) Table 83. North America Cadonilimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 84. North America Cadonilimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 85. United States Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 86. Canada Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 87. Mexico Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 88. Europe Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 91. Europe Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 92. Europe Cadonilimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 93. Europe Cadonilimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 94. Europe Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 97. Europe Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 98. Europe Cadonilimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 99. Europe Cadonilimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 100. Europe Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Cadonilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. Europe Cadonilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. Europe Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. Europe Cadonilimab Injection Sales by Country (2021-2026) & (K Units) Table 105. Europe Cadonilimab Injection Sales by Country (2027-2032) & (K Units) Table 106. Europe Cadonilimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 107. Europe Cadonilimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 108. Germany Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 109. France Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 110. U.K. Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 111. Italy Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 112. Russia Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 113. Spain Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 114. Netherlands Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 115. Switzerland Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 116. Sweden Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 117. Poland Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 118. China Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 119. China Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 120. China Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 121. China Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 122. China Cadonilimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 123. China Cadonilimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 124. China Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 125. China Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 126. China Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 127. China Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 128. China Cadonilimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 129. China Cadonilimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 130. Asia Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 133. Asia Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 134. Asia Cadonilimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Asia Cadonilimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Asia Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 139. Asia Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 140. Asia Cadonilimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Asia Cadonilimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Cadonilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Asia Cadonilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Asia Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Asia Cadonilimab Injection Sales by Country (2021-2026) & (K Units) Table 147. Asia Cadonilimab Injection Sales by Country (2027-2032) & (K Units) Table 148. Asia Cadonilimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Asia Cadonilimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Japan Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 151. South Korea Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 152. India Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 153. Australia Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 154. Taiwan Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 155. Southeast Asia Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 156. SAMEA Cadonilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA Cadonilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA Cadonilimab Injection Sales by Type (2021-2026) & (K Units) Table 159. SAMEA Cadonilimab Injection Sales by Type (2027-2032) & (K Units) Table 160. SAMEA Cadonilimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 161. SAMEA Cadonilimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 162. SAMEA Cadonilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Cadonilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Cadonilimab Injection Sales by Application (2021-2026) & (K Units) Table 165. SAMEA Cadonilimab Injection Sales by Application (2027-2032) & (K Units) Table 166. SAMEA Cadonilimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 167. SAMEA Cadonilimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 168. SAMEA Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. SAMEA Cadonilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. SAMEA Cadonilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. SAMEA Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. SAMEA Cadonilimab Injection Sales by Country (2021-2026) & (K Units) Table 173. SAMEA Cadonilimab Injection Sales by Country (2027-2032) & (K Units) Table 174. SAMEA Cadonilimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 175. SAMEA Cadonilimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Brazil Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 177. Argentina Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 178. Chile Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 179. Colombia Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 180. Peru Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 181. Saudi Arabia Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 182. Israel Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 183. UAE Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 184. Turkey Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 185. Iran Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 186. Egypt Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Cadonilimab Injection Distributors List Table 190. Cadonilimab Injection Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Cadonilimab Injection Image Figure 2. Global Cadonilimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cadonilimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 125 mg (10 mL)/Bottle Image Figure 5. Other Image Figure 6. Global Cadonilimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cadonilimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Lung Cancer Image Figure 9. Liver Cancer Image Figure 10. Cervical Cancer Image Figure 11. Gastric Cancer Image Figure 12. Pancreatic Cancer Image Figure 13. Other Image Figure 14. Global Cadonilimab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Cadonilimab Injection Revenue (2021-2032) & (US$ Million) Figure 16. Global Cadonilimab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Cadonilimab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Cadonilimab Injection Revenue Market Share by Region (2021-2032) Figure 19. Global Cadonilimab Injection Sales (2021-2032) & (K Units) Figure 20. Global Cadonilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Cadonilimab Injection Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Cadonilimab Injection Sales YoY (2021-2032) & (K Units) Figure 23. Europe Cadonilimab Injection Sales YoY (2021-2032) & (K Units) Figure 24. China Cadonilimab Injection Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Cadonilimab Injection Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Cadonilimab Injection Sales YoY (2021-2032) & (K Units) Figure 27. Global Cadonilimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Cadonilimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Cadonilimab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Cadonilimab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Cadonilimab Injection Revenue Market Share by Type (2021-2032) Figure 33. Global Cadonilimab Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Cadonilimab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Cadonilimab Injection Sales Market Share by Type (2021-2032) Figure 36. Global Cadonilimab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Cadonilimab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Cadonilimab Injection Revenue Market Share by Application (2021-2032) Figure 39. Global Cadonilimab Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Cadonilimab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Cadonilimab Injection Sales Market Share by Application (2021-2032) Figure 42. North America Cadonilimab Injection Revenue Share by Type (2021-2032) Figure 43. North America Cadonilimab Injection Sales Share by Type (2021-2032) Figure 44. North America Cadonilimab Injection Revenue Share by Application (2021-2032) Figure 45. North America Cadonilimab Injection Sales Share by Application (2021-2032) Figure 46. North America Cadonilimab Injection Revenue Share by Country (2021-2032) Figure 47. North America Cadonilimab Injection Sales Share by Country (2021-2032) Figure 48. Europe Cadonilimab Injection Revenue Share by Type (2021-2032) Figure 49. Europe Cadonilimab Injection Sales Share by Type (2021-2032) Figure 50. Europe Cadonilimab Injection Revenue Share by Application (2021-2032) Figure 51. Europe Cadonilimab Injection Sales Share by Application (2021-2032) Figure 52. Europe Cadonilimab Injection Revenue Share by Country (2021-2032) Figure 53. Europe Cadonilimab Injection Sales Share by Country (2021-2032) Figure 54. China Cadonilimab Injection Revenue Share by Type (2021-2032) Figure 55. China Cadonilimab Injection Sales Share by Type (2021-2032) Figure 56. China Cadonilimab Injection Revenue Share by Application (2021-2032) Figure 57. China Cadonilimab Injection Sales Share by Application (2021-2032) Figure 58. Asia Cadonilimab Injection Revenue Share by Type (2021-2032) Figure 59. Asia Cadonilimab Injection Sales Share by Type (2021-2032) Figure 60. Asia Cadonilimab Injection Revenue Share by Application (2021-2032) Figure 61. Asia Cadonilimab Injection Sales Share by Application (2021-2032) Figure 62. Asia Cadonilimab Injection Revenue Share by Country (2021-2032) Figure 63. Asia Cadonilimab Injection Sales Share by Country (2021-2032) Figure 64. SAMEA Cadonilimab Injection Revenue Share by Type (2021-2032) Figure 65. SAMEA Cadonilimab Injection Sales Share by Type (2021-2032) Figure 66. SAMEA Cadonilimab Injection Revenue Share by Application (2021-2032) Figure 67. SAMEA Cadonilimab Injection Sales Share by Application (2021-2032) Figure 68. SAMEA Cadonilimab Injection Revenue Share by Country (2021-2032) Figure 69. SAMEA Cadonilimab Injection Sales Share by Country (2021-2032) Figure 70. Cadonilimab Injection Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Cadonilimab Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 125 mg (10 mL)/Bottle
  • Other
Applications
  • Lung Cancer
  • Liver Cancer
  • Cervical Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Other
Companies covered
  • Akeso Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cadonilimab Injection Market by Type
  3. 1.2.1 Global Cadonilimab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 125 mg (10 mL)/Bottle
  5. 1.2.3 Other
  6. 1.3 Cadonilimab Injection Market by Application
  7. 1.3.1 Global Cadonilimab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Lung Cancer
  9. 1.3.3 Liver Cancer
  10. 1.3.4 Cervical Cancer
  11. 1.3.5 Gastric Cancer
  12. 1.3.6 Pancreatic Cancer
  13. 1.3.7 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Cadonilimab Injection Market Dynamics
  1. 2.1 Cadonilimab Injection Industry Trends
  2. 2.2 Cadonilimab Injection Industry Drivers
  3. 2.3 Cadonilimab Injection Industry Opportunities and Challenges
  4. 2.4 Cadonilimab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cadonilimab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cadonilimab Injection Revenue by Region
  3. 3.2.1 Global Cadonilimab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cadonilimab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Cadonilimab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Cadonilimab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cadonilimab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cadonilimab Injection Sales by Region
  9. 3.4.1 Global Cadonilimab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cadonilimab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Cadonilimab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Cadonilimab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cadonilimab Injection Revenue by Manufacturers
  2. 4.1.1 Global Cadonilimab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cadonilimab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cadonilimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cadonilimab Injection Sales by Manufacturers
  6. 4.2.1 Global Cadonilimab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cadonilimab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cadonilimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cadonilimab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cadonilimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cadonilimab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cadonilimab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Cadonilimab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cadonilimab Injection Market CR5 and HHI
  16. 4.8.2 2025 Cadonilimab Injection Tier 1, Tier 2, and Tier 3
5 Cadonilimab Injection Market by Type
  1. 5.1 Global Cadonilimab Injection Revenue by Type
  2. 5.1.1 Global Cadonilimab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cadonilimab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cadonilimab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cadonilimab Injection Sales by Type
  6. 5.2.1 Global Cadonilimab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cadonilimab Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Cadonilimab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cadonilimab Injection Price by Type
6 Cadonilimab Injection Market by Application
  1. 6.1 Global Cadonilimab Injection Revenue by Application
  2. 6.1.1 Global Cadonilimab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cadonilimab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cadonilimab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cadonilimab Injection Sales by Application
  6. 6.2.1 Global Cadonilimab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cadonilimab Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Cadonilimab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cadonilimab Injection Price by Application
7 Company Profiles
  1. 7.1 Akeso Inc.
  2. 7.1.1 Akeso Inc. Company Information
  3. 7.1.2 Akeso Inc. Business Overview
  4. 7.1.3 Akeso Inc. Cadonilimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Akeso Inc. Cadonilimab Injection Product Portfolio
  6. 7.1.5 Akeso Inc. Recent Developments
8 North America
  1. 8.1 North America Cadonilimab Injection Market Size by Type
  2. 8.1.1 North America Cadonilimab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Cadonilimab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Cadonilimab Injection Price by Type (2021-2032)
  5. 8.2 North America Cadonilimab Injection Market Size by Application
  6. 8.2.1 North America Cadonilimab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Cadonilimab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Cadonilimab Injection Price by Application (2021-2032)
  9. 8.3 North America Cadonilimab Injection Market Size by Country
  10. 8.3.1 North America Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cadonilimab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Cadonilimab Injection Market Size by Type
  2. 9.1.1 Europe Cadonilimab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cadonilimab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Cadonilimab Injection Price by Type (2021-2032)
  5. 9.2 Europe Cadonilimab Injection Market Size by Application
  6. 9.2.1 Europe Cadonilimab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cadonilimab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Cadonilimab Injection Price by Application (2021-2032)
  9. 9.3 Europe Cadonilimab Injection Market Size by Country
  10. 9.3.1 Europe Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cadonilimab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Cadonilimab Injection Market Size by Type
  2. 10.1.1 China Cadonilimab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Cadonilimab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Cadonilimab Injection Price by Type (2021-2032)
  5. 10.2 China Cadonilimab Injection Market Size by Application
  6. 10.2.1 China Cadonilimab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Cadonilimab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Cadonilimab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cadonilimab Injection Market Size by Type
  2. 11.1.1 Asia Cadonilimab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cadonilimab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Cadonilimab Injection Price by Type (2021-2032)
  5. 11.2 Asia Cadonilimab Injection Market Size by Application
  6. 11.2.1 Asia Cadonilimab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cadonilimab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Cadonilimab Injection Price by Application (2021-2032)
  9. 11.3 Asia Cadonilimab Injection Market Size by Country
  10. 11.3.1 Asia Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cadonilimab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cadonilimab Injection Market Size by Type
  2. 12.1.1 SAMEA Cadonilimab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cadonilimab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cadonilimab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Cadonilimab Injection Market Size by Application
  6. 12.2.1 SAMEA Cadonilimab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cadonilimab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cadonilimab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Cadonilimab Injection Market Size by Country
  10. 12.3.1 SAMEA Cadonilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cadonilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cadonilimab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cadonilimab Injection Value Chain Analysis
  2. 13.1.1 Cadonilimab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cadonilimab Injection Production Mode & Process
  6. 13.2 Cadonilimab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cadonilimab Injection Distributors
  9. 13.2.3 Cadonilimab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst